A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
Kalbe International Pte. Ltd
The First Affiliated Hospital of Dalian Medical University
Institut Paoli-Calmettes
Assistance Publique Hopitaux De Marseille
University Hospital, Antwerp
Taoyuan General Hospital
Sichuan Cancer Hospital and Research Institute
Central TB Research Institute
The First Affiliated Hospital of Guangzhou Medical University
University of Turin, Italy
Sichuan University
The University of Hong Kong
Peking Union Medical College Hospital
University Hospital, Ghent
Hunan Province Tumor Hospital
The University of Queensland
Sentara Cardiovascular Research Institute
Shanghai Chest Hospital
Vestre Viken Hospital Trust
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lebanese University
Institut Català d'Oncologia
University of South Carolina
Hospices Civils de Lyon
Assiut University
Chang Gung Memorial Hospital
Laibin People's Hospital
Avistone Biotechnology Co., Ltd.
The University of Hong Kong
Massachusetts General Hospital
The First Affiliated Hospital of Guangzhou Medical University
Fudan University
Kineta Inc.
Medical University of Vienna
The First People's Hospital of Lianyungang
Qianfoshan Hospital
Alliance for Clinical Trials in Oncology
Sichuan Cancer Hospital and Research Institute
Shanghai Yunying Medical Technology
Shanghai EpimAb Biotherapeutics Co., Ltd.
Fox Chase Cancer Center
Shanghai Yunying Medical Technology
RenJi Hospital
Manchester University NHS Foundation Trust
Peking University First Hospital
Imperial College Healthcare NHS Trust
Shanghai Pulmonary Hospital, Shanghai, China
Guangzhou Institute of Respiratory Disease
Assistance Publique Hopitaux De Marseille